Japan Mrna Therapeutics Contract Development & Manufacturing Market Size & Outlook
Japan mrna therapeutics contract development & manufacturing market, 2021-2030 (US$M)
Related Markets
Japan mrna therapeutics contract development & manufacturing market highlights
- The Japan mrna therapeutics contract development & manufacturing market generated a revenue of USD 321.4 million in 2023 and is expected to reach USD 646.9 million by 2030.
- The Japan market is expected to grow at a CAGR of 10.5% from 2024 to 2030.
- In terms of segment, infectious diseases was the largest revenue generating indication in 2023.
- Infectious Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.
Mrna therapeutics contract development & manufacturing market data book summary
| Market revenue in 2023 | USD 321.4 million |
| Market revenue in 2030 | USD 646.9 million |
| Growth rate | 10.5% (CAGR from 2023 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Infectious Diseases |
| Historical data | 2021 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Diseases |
| Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
Other key industry trends
- In terms of revenue, Japan accounted for 7.8% of the global mrna therapeutics contract development & manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan mrna therapeutics contract development & manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 257.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Therapeutics Contract Development & Manufacturing Market Scope
MRNA Therapeutics Contract Development & Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan mrna therapeutics contract development & manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Japan mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
Growing initiatives to set up drug discovery infrastructure in Japan, rising investments by private & public sectors, and strategic initiatives such as mergers & acquisitions by key companies are among the key factors fueling the market growth in the country.
For instance, in August 2022, Ricoh Company Ltd. announced the establishment of a Ricoh Biomedical Startup Fund to strengthen support for mRNA drug R&D in Japan. This was following Ricoh’s acquisition of Elixirgen Scientific, Inc.— a CDMO for mRNA drugs—in July 2022. Companies and investors recognize the commercial potential of mRNA therapeutics in Japan and the broader Asia Pacific region.
The growing healthcare needs of the geriatric population and the rising demand for innovative treatments make the mRNA therapeutics contract development & manufacturing organization (CDMO) market in Japan an attractive investment opportunity.
Reasons to subscribe to Japan mrna therapeutics contract development & manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan mrna therapeutics contract development & manufacturing market databook
-
Our clientele includes a mix of mrna therapeutics contract development & manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Japan mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan mrna therapeutics contract development & manufacturing market size, by indication, 2021-2030 (US$M)
Japan MRNA Therapeutics Contract Development & Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
